| Financial Year |
September 30 2021 |
| Monetary Funds |
151,452,039.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
292,123,565.48 |
| Advances to Suppliers |
94,393,230.08 |
| Other Receivables |
279,429,822.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
106,064,307.43 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,458,575.43 |
| Total Current Assets |
819,857,232.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,332,341,171.18 |
| Investment Properties |
-- |
| Fixed Assetes |
1,952,767.90 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,568,321.03 |
| R&D expenses |
-- |
| Goodwill |
450,000.00 |
| Long-Term Deferred and Prepaid Expenses |
916,304.70 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,432,033,963.91 |
| Total Assets |
2,251,891,196.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,351,018.54 |
| Accounts Received In Advance |
9,383,262.04 |
| Employee Compensation Payable |
1,160,075.20 |
| Taxes Payable |
4,008,226.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,501,688.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
712,095.07 |
| Sub-Total of Current Liabilities |
78,616,358.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
21,000,000.00 |
| Sub-Total of Non-Current Liabilities |
21,000,000.00 |
| Total Liabilities |
99,616,358.98 |
| Paid-In Capital(Or Share Stock) |
1,844,896,231.00 |
| Capital Surplus |
3,091,019,828.96 |
| Surplus Reserve |
24,402,707.78 |
| LESS:Treasury Stock |
30,011,327.40 |
| Undistributed Profits |
-2,384,215,613.75 |
| Minority Stockholder's Interest |
35,555,620.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,116,719,217.32 |
| Owner's Equity（Stockholder's Equity） |
2,152,274,837.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,251,891,196.48 |
